Skip to main content
ARDELYX, INC. logo

ARDELYX, INC. — Investor Relations & Filings

Ticker · ARDX ISIN · US0396971071 LEI · 549300F542QR4SXHCY32 US Manufacturing
Filings indexed 1,078 across all filing types
Latest filing 2018-02-12 Board/Management Inform…
Country US United States of America
Listing US ARDX

About ARDELYX, INC.

https://www.ardelyx.com/

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically announces the departure of a senior executive, the Chief Scientific Officer, effective on a certain date. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and focused solely on this management change, with no financial data or other report content. Therefore, the correct classification is MANG with high confidence.
2018-02-12 English
SC 13G/A
Major Shareholding Notification
2018-02-12 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-01 English
FORM 4
Director's Dealing
2018-01-19 English
FORM 4
Director's Dealing
2018-01-19 English
FORM 4
Director's Dealing
2018-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.